Northwest Biotherapeutics Receives MHRA Approval of License for GMP Manufacturing in UK
Northwest Biotherapeutics, a Biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, has announced that approval has been received from the UK Medicines and Healthcare Products Regulatory Agency ( MHRA ) of a license for manufacture of GMP (clinical grade) Cell therapy products at its Sawston, UK facility.
The MHRA license approval enables the manufacturing of DCVax-L products to get under way at the Sawston facility in addition to continuing at the smaller GMP Facility in London. The license also permits the import and GMP manufacture of other Cell Therapy products under the UK
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!